Consolidated Balance Sheets
(In thousands)
| September 30, | December 31, |
| 2018 | 2017 |
| U.S. Dollars (In thousands) | |
Assets |
|
|
|
|
|
Current assets |
|
|
Cash and cash equivalents | 48,328 | 43,744 |
Trade accounts receivable, net | 30,746 | 23,153 |
Inventories | 25,789 | 21,336 |
Other current assets | 3,536 | 3,215 |
Total current assets | 108,399 | 91,448 |
Fixed assets, net | 15,798 | 15,503 |
Long-term inventory | 1,799 | 1,383 |
Deferred tax asset | 2,890 | 4,067 |
Other assets, net | 153 | 153 |
Intangible assets, net | 508 | 482 |
| 5,350 | 6,085 |
Total assets | 129,547 | 113,036 |
|
|
|
Liabilities and shareholders' equity |
|
|
Current liabilities |
|
|
Trade accounts payable | 13,746 | 10,502 |
Other current liabilities | 20,127 | 17,395 |
Total current liabilities | 33,873 | 27,897 |
Long term liabilities |
|
|
Liability for employee severance benefits | 873 | 838 |
| 873 | 838 |
Total liabilities | 34,746 | 28,735 |
|
|
|
Shareholders' equity |
|
|
38,526,231 issued shares at September 30, 2018 and 37,924,507 at December 31, 2017; |
|
|
Additional paid-in capital | 81,040 | 78,437 |
Retained earnings | 15,508 | 7,613 |
| 96,699 | 86,199 |
Treasury stock, at cost (2,092,376 as of September 30, 2018 and December 31, 2017) |
(1,898) |
(1,898) |
Total shareholders' equity | 94,801 | 84,301 |
Total liabilities and shareholders' equity | 129,547 | 113,036 |
Consolidated Statements of Operations
(in thousands, except share data)
|
| Nine Months ended | Three months ended | Year ended | ||||
|
| September 30, | September 30, | December 31, | ||||
|
| 2018 | 2017 | 2018 | 2017 | 2017 | ||
|
| U.S. dollars | U.S. dollars | U.S. dollars | ||||
Revenues |
| 90,000 | 67,641 | 32,264 | 23,813 | 93,485 | ||
Cost of revenues |
| 45,921 | 34,447 | 16,081 | 12,063 | 47,966 | ||
|
|
|
|
|
|
| ||
Gross profit |
| 44,079 | 33,194 | 16,183 | 11,750 | 45,519 | ||
|
|
|
|
|
|
| ||
Research and development costs |
| 10,456 | 10,067 | 3,501 | 3,215 | 13,534 | ||
Selling, general and administrative expenses |
| 19,792 | 16,847 | 7,128 | 5,688 | 22,022 | ||
Patent litigation expense |
| - | 13,000 | - | - | 13,000 | ||
|
|
|
|
|
|
| ||
Total operating expenses |
| 30,248 | 39,914 | 10,629 | 8,903 | 48,556 | ||
|
|
|
|
|
|
| ||
Operating income (loss) |
| 13,831 | (6,720) | 5,554 | 2,847 | (3,037) | ||
|
|
|
|
|
|
|
| |
Financial income (expenses), net |
| 491 | (199) | 55 | 10 | (150) | ||
|
|
|
|
|
|
|
| |
Income (loss) from continuing operations |
|
|
|
|
|
|
| |
before income taxes |
| 14,322 | (6,919) | 5,609 | 2,857 | (3,187) | ||
|
|
|
|
|
|
|
| |
Income tax benefit (expense) |
| (1,364) | 5,281 | (516) | (83) | 4,875 | ||
|
|
|
|
|
|
|
| |
Income (loss) from continuing operations |
| 12,958 | (1,638) | 5,093 | 2,774 | 1,688 | ||
|
|
|
|
|
|
|
| |
Discontinued operation |
|
|
|
|
|
|
| |
Income from discontinued operation |
|
|
|
|
|
|
| |
Income before tax benefit (expense) |
|
| - | 18,302 | - | 13,963 | 18,302 | |
Income tax benefit (expense) |
|
| - | (5,563) | - | (5,058) | (6,028) | |
|
|
|
|
|
|
|
| |
Income from discontinued operation |
|
| - | 12,739 | - | 8,905 | 12,274 | |
|
|
|
|
|
|
|
| |
Net income |
| 12,958 | 11,101 | 5,093 | 11,679 | 13,962 | ||
|
|
|
|
|
|
|
| |
Net income (loss) per ordinary share: |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
Basic earnings (loss) from continuing operation |
|
| 0.36 | (0.05) | 0.14 | 0.08 | 0.05 | |
|
|
|
|
|
|
|
| |
Basic earnings from discontinued operation |
|
| - | 0.36 | - | 0.25 | 0.35 | |
|
|
|
|
|
|
|
| |
Diluted earnings (loss) from continuing operation |
|
| 0.35 | (0.05) | 0.14 | 0.08 | 0.05 | |
|
|
|
|
|
|
|
| |
Diluted earnings from discontinued |
|
|
|
|
|
|
| |
operation |
|
| - | 0.35 | - | 0.24 | 0.34 | |
|
|
|
|
|
|
|
| |
Weighted average number of |
|
|
|
|
|
|
| |
ordinary shares outstanding: |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
Basic |
|
| 36,105 | 35,374 | 36,300 | 35,404 | 35,441 | |
|
|
|
|
|
|
|
| |
Diluted |
|
| 36,657 | 35,972 | 36,941 | 36,361 | 35,964 | |
|
|
|
|
|
|
|
|
|